|Other names||LY-79907; 2-Chloro-6-methylergoline-8β-acetonitrile|
|Chemical and physical data|
|Molar mass||299.80 g·mol−1|
|3D model (JSmol)|
Lergotrile (INN, USAN) is an ergoline derivative which acts as a dopamine receptor agonist. It was developed for the treatment of Parkinson's disease, but failed in clinical trials due to liver toxicity.